TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 176 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $386,047 | -41.8% | 43,182 | 0.0% | 0.00% | – |
| Q2 2023 | $663,275 | -31.7% | 43,182 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $971,163 | +78346.1% | 43,182 | -26.7% | 0.00% | 0.0% |
| Q4 2022 | $1,238 | -99.9% | 58,873 | -11.3% | 0.00% | 0.0% |
| Q3 2022 | $1,635,000 | +1.7% | 66,362 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,608,000 | -6.1% | 66,362 | -0.1% | 0.00% | 0.0% |
| Q1 2022 | $1,712,000 | +25.1% | 66,445 | +50.6% | 0.00% | 0.0% |
| Q4 2021 | $1,369,000 | +100.4% | 44,118 | +56.6% | 0.00% | – |
| Q3 2021 | $683,000 | +112.1% | 28,180 | +27.7% | 0.00% | – |
| Q2 2021 | $322,000 | -41.6% | 22,070 | 0.0% | 0.00% | – |
| Q1 2021 | $551,000 | -8.5% | 22,070 | 0.0% | 0.00% | – |
| Q4 2020 | $602,000 | – | 22,070 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |